Editas Medicine (EDIT) EBT Margin Growth (5y) (2020 - 2025)
Editas Medicine (EDIT) EBT Margin Growth (5y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Editas Medicine | 245.95 Mn | 99.30 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -39,599.00 |
| Jun 30, 2025 | -100,160.00 |
| Mar 31, 2025 | -82,867.00 |
| Dec 31, 2024 | 12,861.00 |
| Sep 30, 2024 | -10.06 Mn |
| Jun 30, 2024 | -1.08 Mn |
| Mar 31, 2024 | -327,471.00 |
| Dec 31, 2023 | 71,345.00 |
| Sep 30, 2023 | -204,842.00 |
| Jun 30, 2023 | -1.61 Mn |
| Mar 31, 2023 | -51,263.00 |
| Sep 30, 2022 | -378.47 Mn |
| Jun 30, 2022 | -1.55 Mn |
| Mar 31, 2022 | -4.99 Mn |
| Dec 31, 2021 | 448,316.00 |
| Sep 30, 2021 | 230,598.00 |
| Jun 30, 2021 | -3.29 Mn |
| Mar 31, 2021 | 800,625.00 |
| Dec 31, 2020 | 294,130.00 |
| Sep 30, 2020 | 110,305.00 |